Skip to search.
 BSE Down 0.02% NSE Down 0.23%

ZIOPHARM Oncology, Inc. (ZIOP)

-NasdaqCM
6.10 Down 0.11(1.77%) 25 Feb 2:30am
|After Hours : 6.10 0.00 (0.00%) 25 Feb 4:04am
Prev Close:6.21
Open:6.18
Bid:5.41 x 100
Ask:6.77 x 10000
1y Target Est:23.00
Beta:1.92788
Earnings Date:8 May - 12 May (Est.)
Day's Range:6.05 - 6.31
52wk Range:4.45 - 9.74
Volume:1,586,056
Avg Vol (3m):1,688,090
Market Cap:795.83M
P/E (ttm):N/A
EPS (ttm):-1.32
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ZIOP at this time.

Comparison

Symbol% ChgMkt Cap
ZIOPDown 1.77%795.83M
IMGNUp 3.83%236.59M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):118.30
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-17) :-0.57
Quarterly EPS Est (Mar-17) :-0.12
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ZIOPHARM Oncology, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing a portfolio of cancer therapies that address unmet medical needs through synthetic immuno-oncology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback